Faverin 100 100 mg. FC tablets
PDF Leaflet Revision Date: 13 February 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive episodes and severe obsessive-compulsive disorder.
Dosage (summary)
Starting dose 100 mg/day, max 300 mg/day; adjust based on response.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- MAOIs
- Tizanidine
- Pimozide
- Lithium
- Warfarin
Contraindications
- Hypersensitivity to fluvoxamine
- Pregnancy
- Lactation
- Children
- Liver dysfunction
- Epilepsy
Common side effects
- Nausea
- Dizziness
- Somnolence
- Agitation
- Anxiety
Counselling Points
- Monitor for suicidal thoughts
- Avoid alcohol
- Gradually taper off when discontinuing
Serious warnings
- Risk of suicidal thoughts
- Serotonin syndrome
- Akathisia
Important Disclaimer
The Faverin 100 100 mg. FC tablets professional information leaflet below is the property of Abbott Laboratories South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
